What are the differences between MRI, ultrasound, and FibroScan in evaluating the liver?

Comparison of Liver Imaging Tests: MRI Elastography, Ultrasound Elastography, and FibroScan

For evaluating liver fibrosis, MRI elastography (MRE) is the most accurate imaging method, followed by FibroScan (transient elastography/TE), with standard ultrasound being the least accurate for fibrosis staging. 1

Key Differences Between These Tests

MRI Elastography (MRE)

• Highest diagnostic accuracy across all stages of fibrosis, with sensitivities of 89-93% and specificities of 92-94% for detecting significant fibrosis, advanced fibrosis, and cirrhosis 1
• Provides elasticity measurements of the entire liver, not just a small region 2
• Superior performance particularly for detecting significant fibrosis (F2-4) and advanced fibrosis (F3-4) 3
• In head-to-head comparisons with FibroScan in chronic hepatitis B patients, MRE showed significantly higher diagnostic accuracy (AUROC 0.981 vs 0.796 for significant fibrosis, p<0.001) 3
• Limitations: Higher cost, limited availability, cannot be used with certain metal implants, time-consuming 4

FibroScan/Transient Elastography (TE)

• Most widely validated and available elastography method with the largest body of evidence 1
• Sensitivities range from 72-80% and specificities from 82-87% for detecting various stages of fibrosis 3
• Provides results in real-time within minutes, requires only 2-3 hours fasting 4
• Applicability >95% in non-obese patients, relatively short training required 4
• Measures liver stiffness in a localized region of the right liver lobe 2
• Critical confounders that artificially elevate readings: active inflammation, obstructive cholestasis, recent food intake, exercise, venous congestion—these must be excluded before interpretation 1, 4
• Higher measurement variability compared to MRE 2

Standard Ultrasound

• Not accurate for staging fibrosis—cannot reliably diagnose initial or moderate stages of fibrosis 4
• For detecting fatty liver (steatosis), ultrasound has moderate sensitivity (73%) and specificity (69%) compared to FibroScan 5
• Operator-dependent, limited by obesity and abdominal gas 4
• Should not be used alone for assessing liver disease advancement 6

Practical Clinical Algorithm

For fibrosis staging:

1. First-line: Use FibroScan (TE) due to widespread availability, speed, and acceptable accuracy

   • Ensure 3+ hours fasting, exclude inflammation/cholestasis/congestion
   • Cutoff values: <5.2 kPa excludes significant fibrosis; ≥8.9 kPa confirms it (correctly classifies 64% of patients) 7

2. When FibroScan is inconclusive or unavailable: Order MRE

   • MRE cutoffs: <1.66 kPa excludes significant fibrosis; ≥2.18 kPa confirms it 7
   • This conditional strategy increases diagnostic accuracy to 80% 7

3. Reserve liver biopsy for cases where both non-invasive tests are inconclusive or contradictory

For steatosis detection:

• FibroScan with CAP (controlled attenuation parameter) or newer attenuation imaging (ATI) with ultrasound are both effective 8
• Standard ultrasound alone is insufficient 6

Important Caveats

• All elastography methods measure liver stiffness, which reflects fibrosis but is also affected by inflammation, congestion, and cholestasis—these are not interchangeable with fibrosis stage 1, 4
• Accuracy increases progressively from detecting moderate fibrosis (F2-4) to advanced fibrosis (F3-4) to cirrhosis (F4), with cirrhosis detection being most reliable 1
• Cutoff values differ by liver disease etiology (hepatitis B vs C vs fatty liver) and between adults and children 1
• Imaging-based tests consistently outperform blood-based tests for detecting advanced fibrosis and cirrhosis 1
• A drop in stiffness values after treatment (e.g., antiviral therapy) may reflect inflammation resolution rather than fibrosis improvement 1